Overview of the Q1 FY ending March 2027 results. Revenue increased versus the prior period, with improvements in operating income and ordinary income. The briefing material includes segment trends, outlook, and a Q&A section. Key topics highlighted include new order intake, R&D investment trends, and changes in cost structure.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2395","jir_company_name":"Shin Nippon Science Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2395-20260805-02.pdf","jir_short_summary":"Overview of the Q1 FY ending March 2027 results. Revenue increased versus the prior period, with improvements in operating income and ordinary income. The briefing material includes segment trends, outlook, and a Q&A section. Key topics highlighted include new order intake, R&D investment trends, and changes in cost structure.","jir_summary":"### Section Heading\nUnder the new management structure and future policy, the company emphasizes growth centered on the CRO business, expansion of non-clinical orders, trends in Satsuma-related businesses, and policy on investment activities. In the first quarter of the results briefing, revenue is presented as a positive factor, with a section comparing Q1 actuals to future outlook.\n\n### Section 2 Heading\nFuture directions include improving CRO profitability and investment efficiency, expansion of Satsuma-related businesses, M&A and partnership trends, and responses to market trends post-COVID-19. Related charts and tables accompany quarterly revenue and profit trends and departmental structure analyses, aiming to balance short-term outlook with long-term strategy.","jir_financial_highlights":"Revenue: Unknown (+21.5% (context referencing comparisons with FY3\/25\u2192FY3\/27, etc.))\nOperating income: Unknown (Quarter-over-quarter change is unknown)\nOrdinary income: Unknown (Quarter-over-quarter change is unknown)\nNet income attributable to owners of parent: Unknown (Unknown)","jir_category":"","jir_hashtags":"#ShinNihonKagaku, #IR, #JapaneseStocks","jir_key_figures":"Revenue: Unknown (fallback when specific values are not disclosed in the financial summary)\nOperating income: Unknown\nOrdinary income: Unknown","jir_meta_title":"\u3010Shin Nippon Kagaku\u3011Q1 FY March 2027 Financial Results Overview | Revenue Trends and Future Strategy","jir_meta_description":"Analysis of Shin Nippon Kagaku's FY2027 Q1 financial results overview. Key points include revenue and profit movements, contributions by segment, and forthcoming investment plans and business strategy.","jir_og_title":"Shin Nippon Kagaku Financial Results Briefing: Q1 Trends and Strategy","jir_og_description":"Shin Nippon Kagaku's FY2027 Q1 results overview. Explains revenue growth and a CRO-centric growth strategy, along with outlook.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":17048,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-95959","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n